BCAX
Bicara Therapeutics Inc.
$18.54
+$0.76(+4.27%)
63
Overall
80
Value
75
Tech
34
Quality
Market Cap
$991.41M
Volume
841.68K
52W Range
$7.80 - $28.09
Target Price
$33.00
EPS Estimates Overview
| Current Quarter | $-0.55 | Next Quarter | $-0.6 |
| Current Year | $-2.32 | Next Year | $-2.71 |
| QoQ Growth | -9.1% | YoY Growth | -16.8% |
| 3Y EPS CAGR | N/A | Target Price | $33.00 |
| Consensus | Buy | Upside | +78.0% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $18.54 | +4.3% | 841.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW